The psychopharmacology of tachykinin NK-3 receptors in laboratory animals

被引:60
作者
Massi, M [1 ]
Panocka, I
de Caro, G
机构
[1] Univ Camerino, Dept Pharmacol Sci & Expt Med, I-62032 Camerino, Italy
[2] Mil Inst Hyg & Epidemiol, Dept Pharmacol & Toxicol, PL-10163 Warsaw, Poland
[3] Univ Parma, Sch Med, Inst Pharmacol, I-43100 Parma, Italy
关键词
tachykinins; NK-3 receptor agonists; NK-3 receptor antagonists; reward; drug abuse; anxiety; depression;
D O I
10.1016/S0196-9781(00)00291-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present article reviews the studies so far published on the psychopharmacological effects mediated by tachykinin NK-3 receptors in laboratory animals. Central administration of NK-3 receptor agonists has been reported to attenuate alcohol intake in alcohol-preferring rats and to evoke conditioned place preference. These findings suggest that NK-3 receptors may affect reward processes to drugs of abuse. Anxiolytic-like and antidepressant-like effects have been previously reported for NK-1 receptor antagonists, and anxiolytic-like effects for NK-2 receptor antagonists. More recently, it has been shown that NK-3 receptor agonists have anxiolytic-like and antidepressant-like effects in mice and rats, while an NK-3 receptor antagonist was reported to be anxiogenic in mice. These findings indicate that different TK receptor subtypes may be involved in anxiolytic-like and antidepressant-like effects in laboratory animals and raise interest for the possible role of NK-3 receptors in the control of anxiety and depression in man. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1597 / 1609
页数:13
相关论文
共 149 条
[1]   The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide [J].
Ågmo, A ;
Belzung, C .
NEUROPHARMACOLOGY, 1998, 37 (02) :223-232
[2]   Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures [J].
Alonso, R ;
Fournier, M ;
Carayon, P ;
Petitpretre, G ;
LeFur, G ;
Soubrie, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (04) :801-808
[3]   Substance P antagonists: the next breakthrough in treating depression? [J].
Baby, S ;
Nguyen, M ;
Tran, D ;
Raffa, RB .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (06) :461-469
[4]   Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801 [J].
Beaujouan, JC ;
Saffroy, M ;
Torrens, Y ;
Glowinski, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 319 (2-3) :307-316
[5]   Naloxone potentiates the anxiolytic but not the amnestic action of chlordiazepoxide in C57BL/6 mice [J].
Belzung, C ;
Dubreuil, D .
BEHAVIOURAL PHARMACOLOGY, 1998, 9 (08) :691-698
[6]   INVOLVEMENT OF ENDOGENOUS ENKEPHALINS IN THE MOUSE BEHAVIORAL DESPAIR TEST [J].
BENNATAN, L ;
CHAILLET, P ;
LECOMTE, JM ;
MARCAIS, H ;
UCHIDA, G ;
COSTENTIN, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 97 (3-4) :301-304
[7]   THE RATIONAL DEVELOPMENT OF SMALL-MOLECULE TACHYKININ NK(3) RECEPTOR-SELECTIVE ANTAGONISTS - THE UTILIZATION OF A DIPEPTIDE CHEMICAL LIBRARY IN DRUG DESIGN [J].
BODEN, P ;
EDEN, JM ;
HODGSON, J ;
HORWELL, DC ;
HOWSON, W ;
HUGHES, J ;
MCKNIGHT, AT ;
MEECHAM, K ;
PRITCHARD, MC ;
RAPHY, J ;
RATCLIFFE, GS ;
SUMANCHAUHAN, N ;
WOODRUFF, GN .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (14) :1679-1684
[8]   PRESENCE OF NK3-SENSITIVE NEURONS IN DIFFERENT PROPORTIONS IN THE MEDIAL HABENULA OF GUINEA-PIG, RAT AND GERBIL [J].
BODEN, P ;
WOODRUFF, GN .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) :717-719
[9]   EFFECTS OF SUBSTANCE-P ON EXTRACELLULAR DOPAMINE IN NEOSTRIATUM AND NUCLEUS-ACCUMBENS [J].
BOIX, F ;
MATTIOLI, R ;
ADAMS, F ;
HUSTON, JP ;
SCHWARTING, RKW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 216 (01) :103-107
[10]   RELATIONSHIP BETWEEN DOPAMINE RELEASE IN NUCLEUS-ACCUMBENS AND PLACE PREFERENCE INDUCED BY SUBSTANCE-P INJECTED INTO THE NUCLEUS BASALIS MAGNOCELLULARIS REGION [J].
BOIX, F ;
SANDOR, P ;
NOGUEIRA, PJC ;
HUSTON, JP ;
SCHWARTING, RKW .
NEUROSCIENCE, 1995, 64 (04) :1045-1055